v3.26.3
Shareholders' Equity - Narrative (Details) - USD ($)
$ / shares in Units, shares in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Oct. 20, 2026
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Unrecognized compensation cost $ 64,142,000   $ 64,142,000    
Total intrinsic value of options exercised     87,923,000    
Aggregate intrinsic value of options exercisable $ 255,110,000   $ 255,110,000    
Market value of Company's common stock (in USD per share) $ 102.66   $ 102.66    
Weighted average exercise price per share (in USD per share) $ 59.73   $ 59.73    
Total options outstanding (in shares) 11,154   11,154    
Total options exercisable (in shares) 5,942   5,942    
Anti-dilutive employee stock options (in shares) 4,368 5,687 4,396 5,744  
Anti-dilutive employee stock options (in USD per share) $ 75.30 $ 66.09 $ 75.28 $ 66.04  
Dividends declared per common share (in USD per share) $ 0 $ 0 $ 0.52 $ 0.49  
Cash dividends declared     $ 63,045,000 $ 61,478,000  
Common Stock Buyback          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares purchased and retired (in shares)     5,890    
Company purchased, cost     $ 535,752,000    
Common Stock Buyback | Subsequent Event          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock repurchase program, increased amount         $ 800,000,000
Remaining stock repurchase authorization amount         $ 925,643,000